Abstract | BACKGROUND: METHODS: RESULTS: The effects of Flu-Met were similar whether combined with oral or transdermal contraceptive. In both groups, CRP and TNF-alpha levels fell and the high neutrophil/lymphocyte ratio normalized (P < 0.001). Lean body mass increased (P < 0.001) in both groups but, in contrast to earlier experience with continuous Flu-Met, fat mass failed to decrease in either group. CONCLUSIONS: Flu-Met seems less lipolytic, if given for only 21 days in every 28-day period. The efficacy of Flu-Met is comparable when combined with an oral contraceptive or a transdermal contraceptive. The range of Flu-Met effects may henceforth include lower levels of CRP and TNF-alpha, and a normalization of the neutrophil/lymphocyte ratio.
|
Authors | Lourdes Ibáñez, Carme Valls, Francis de Zegher |
Journal | Human reproduction (Oxford, England)
(Hum Reprod)
Vol. 21
Issue 2
Pg. 451-6
(Feb 2006)
ISSN: 0268-1161 [Print] England |
PMID | 16239318
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Contraceptive Agents, Female
- Contraceptives, Oral
- Tumor Necrosis Factor-alpha
- Flutamide
- C-Reactive Protein
- Metformin
|
Topics |
- Administration, Cutaneous
- Adolescent
- Adult
- C-Reactive Protein
(analysis)
- Contraceptive Agents, Female
(administration & dosage, therapeutic use)
- Contraceptives, Oral
(administration & dosage, therapeutic use)
- Drug Therapy, Combination
- Female
- Flutamide
(administration & dosage, therapeutic use)
- Humans
- Hyperandrogenism
(blood, drug therapy)
- Hyperinsulinism
(blood, drug therapy)
- Leukocyte Count
- Lymphocytes
(drug effects)
- Metformin
(administration & dosage, therapeutic use)
- Neutrophils
(drug effects)
- Tumor Necrosis Factor-alpha
(analysis)
|